תבנית:תרופה/וקטור פלוס 160/25 - Vector plus 160/25

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	C09CA Angiotensin II antagonists, plain C03AA Thiazides, plain
××¨××× ×¤×¢×× (ATC5)	Â Hydrochlorothiazide 25MG Hydrochlorothiazide 25MG Valsartan 160MG Angiotensin ii antagonists, plain C09CA Thiazides, plain C03AA 7290008546713 ×× Kibbutz maabarot 4023000, ISRAEL Hydrochlorothiazide 25MG Valsartan 160MG
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	For the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. This fixed combination should be used as second-line therapy.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/××§×××¨ ×¤×××¡ 160/25 - Vector plus 160/25
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××××¨× ××¢××× ××××¨× ××¢××× ××××¨× ××¢×××

×¢××× ××¦×¨××	×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××§×××¨ ×¤×××¡ 160/25 Â® ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL
×©× ××¢× ××¨××©××	UNIPHARM LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 01/2010. ×¨××©××× ××ª××¨××: 04/2016
×ª××¨×× ×¢×××× ×××¨××	15/05/19

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/25}}

×:

{{×ª×¨××¤×/25
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־25 באפריל 2021 ב־18:47

ויקיתרופות